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Introduction: The value of gastric intramucosal pH (pHi) can be calculated from the tonometrically measured
partial pressure of carbon dioxide (PCO2 ) in the stomach and the arterial bicarbonate content. Low pHi and increase
of the difference between gastric mucosal and arterial PCO2 (PCO2 gap) reflect splanchnic hypoperfusion and are good
indicators of poor prognosis. Some randomized controlled trials (RCTs) were performed based on the theory that
normalizing the low pHi or PCO2 gap could improve the outcomes of critical care patients. However, the conclusions of
these RCTs were divergent. Therefore, we performed a systematic review and meta-analysis to assess the effects of this
goal directed therapy on patient outcome in Intensive Care Units (ICUs).
Methods: We searched PubMed, EMBASE, the Cochrane Library and ClinicalTrials.gov for randomized controlled trials
comparing gastric tonometry guided therapy with control groups. Baseline characteristics of each included RCT
were extracted and displayed in a table. We calculated pooled odds ratios (ORs) with 95% confidence intervals (CIs)
for dichotomous outcomes. Another measure of effect (risk difference, RD) was used to reassess the effects of gastric
tonometry on total mortality. We performed sensitivity analysis for total mortality. Continuous outcomes were presented
as standardised mean differences (SMDs) together with 95% CIs.
Results: The gastric tonometry guided therapy significantly reduced total mortality (OR, 0.732; 95% CI, 0.536 to 0.999,
P = 0.049; I2 = 0%; RD, −0.056; 95% CI, −0.109 to −0.003, P = 0.038; I2 = 0%) when compared with control groups. However,
after excluding the patients with normal pHi on admission, the beneficial effects of this therapy did not exist (OR, 0.736;
95% CI 0.506 to 1.071, P = 0.109; I2 = 0%). ICU length of stay, hospital length of stay and days intubated were not
significantly improved by this therapy.
Conclusions: In critical care patients, gastric tonometry guided therapy can reduce total mortality. Patients with normal
pHi on admission contributed to the ultimate result of this outcome; it may indicate that these patients may be more
sensitive to this therapy.Introduction
Gastric tonometry is a technique designed to measure
partial pressure of carbon dioxide (PCO2 ) in the stomach.
Carbon dioxide produced by mucosa can easily diffuse
into the lumen of the stomach to gain balance of PCO2
between mucosa and the lumen. The change of PCO2 in
the stomach can reflect variation of the blood flow [1].
When the perfusion of gastric mucosa reduces, carbon
dioxide will accumulate in the mucosa due to a reduction* Correspondence: wqp1968@126.com
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unless otherwise stated.in removal [1]. Gastric intramucosal pH (pHi) is an index
being calculated from the tonometrically measured PCO2
and the arterial bicarbonate content (assuming mucosa
bicarbonate equals arterial bicarbonate) using the
Henderson–Hasselbalch equation. It is also an index
to evaluate the adequacy of gastrointestinal mucosal
perfusion, a fall in which may reflect a reduction of
splanchnic blood flow [2-4]. More specifically, the pHi
variables are indicators of the blood flow to demand
ratio [4]. A recently published study showed that
exercise-induced splanchnic hypoperfusion could lead
to measurable small intestinal injury [5]. Transient
normotensive hypovolemia may result in splanchnic
vasoconstriction [6] and this early change could be
detected by the measurement of tonometry [7]. InadequateThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Baseline characteristics of included randomized controlled trials
Authors Population Mean (SD)
age
Mean (SD) APACHE II
scores on admission






Inclusion criteria: medical and
surgical patients consecutively
admitted to ICUs with APACHE II





pHi guided: if the pHi was below
7.35 or had fallen by 0.10 units or
more from the previous reading,
normal saline, dobutamine was











Control: 19.10 (2.75) Control:
125
Exclusion criteria: patients with
esophageal varices or esophageal or
nasopharyngeal obstructions. Control: patients were treated
according to the conventional




Inclusion criteria: any patient
with trauma injury who had
substantial and prolonged
hypotension in the prehospital
period, emergency department,
or operating room, an Injury
Severity Score >25, an initial
base deficit >5 mol/l, or an initial
blood lactate level >4 mmol/L.
pHi guided:
27 (11.1)
pHi guided: − pHi guided: the oxygen delivery
index (DO2I) was increased
progressively by crystalloid and
blood infusion to a pulmonary
capillary wedge pressure of
18 mmHg and a hematocrit of
35%. If pHi was not corrected,
inotropic therapy with
dobutamine hydrochloride (5 to
10 μg/kg/minute) was started.
All patients in both groups
received a low-dose dopamine
(2 to 5 μg/kg/minute) infusion
as a renal vasodilator. A histamine
H2-receptor antagonist (cimetidine)









Control: the goal of therapy was
to achieve and maintain a DO2I
of 600 ml/minute/m2 or greater,
or an oxygen consumption index
of 150 ml/minute/m2 or greater,
or both.
Exclusion criteria: patients who
died of exsanguinating hemorrhage
within 24 hours of injury were




scheduled for elective repair




pHi guided: 11 (4) pHi guided: pHi values lower
than 7.32 were treated by the
attending physician according
to a predefined treatment flow
chart (Figure 1 [20]).
Starting on the day of surgery,










Control: 12 (5) Control: 26
Exclusion criteria: not mentioned.
Control: treatment was performed
according to the usual clinical
guidelines: hemodynamics were





Inclusion criteria: a total of 210 adult
patients, with a median APCAHE II





pHi guided: after achieving the
basic targets, if the pHi <7.35,
patients were given additional
colloid and then a dobutamine
infusion at 5 and then 10 μg/kg/
minute, titrated against pHi
(Figures 2 and 3 [16]).
Specific therapy to treat the
patients’ underlying disease and
other forms of organ dysfunction
were prescribed as indicated














106Exclusion criteria: a primary
admission diagnosis of cardiogenic
pulmonary edema, asthma, isolated
neurologic trauma, intracerebral
hemorrhage, or active gastrointestinal
bleeding or contraindications to the
Control: achieve the basic









Table 1 Baseline characteristics of included randomized controlled trials (Continued)
insertion of a nasogastric tube or to
the use of dobutamine.
Hameed and
colleagues [18]
Inclusion criteria: trauma patients
admitted to the TICU met entry
criteria for the study by definition.
pHi guided:
−
pHi guided: − pHi guided: if pHi was
















ICU length of stay,
hospital length of
stay, mortality.Control: − Control: − Control: 54
Exclusion criteria: patients arrived
more than 12 hours post injury,
were pronounced brain dead in the
TICU, were pronounced dead in the
resuscitation area or operating





parameters such as blood
pressure, urine output,
cardiac output, or systemic
indicators of hypoperfusion
such as lactate, base deficit,
pH, or mixed venous oxygenation,
crystalloid, colloid, blood products.
Palizas and
colleagues [19]
Inclusion criteria: adult patients
fulfilling criteria for septic shock
according to the ACCP/SCCM
Consensus Conference within
48 hours of ICU admission were
considered and selected if they





pHi guided: after achieving the
basic goal, if the pHi was lower
than 7.32, crystalloids/colloids,
dobutamine were used to make

















Control: using the common
hemodynamic protocol to
reach the common physiological
objectives, making the CI ≥ 3.4 l/
minute/m2 (Figure 1 [19]).
Exclusion criteria: terminal illness
with the patient expected to die
within 28 days, irreversible neurologic
impairment, and contraindication for
nasogastric tube placement.
ACCP/SCCM, American College of Chest Physicians/ Society of Critical Care Medicine; APACHE, Acute Physiology and Chronic Health Evaluation; CI, cardiac index; pHi, intramucosal pH; SD, standard deviation; SICU,
















Blinding of the pHi













Low risk Low risk Low risk Low risk Low risk Unclear risk
Ivatury and
colleagues [17]
Low risk Low risk Low risk Low risk Low risk Unclear risk
Pargger and
colleagues [20]
Unclear risk Unclear risk Low risk Low risk Low risk Unclear risk
Gomersall and
colleagues [16]
Low risk Low risk Unclear risk Low risk Low risk Unclear risk
Hameed and
colleagues [18]
Low risk Low risk Unclear risk Low risk Low risk Unclear risk
Palizas and
colleagues [19]
Unclear risk Unclear risk Low risk Low risk Low risk Unclear risk
pHi, intramucosal pH.
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endotoxin translocation and gut wall inflammation, and this
may cause some patients to develop multiple organ
dysfunction syndrome [8-11]. Nordin and colleagues
performed an in vivo study, which indicated that the
pHi was valuable for early outcome assessment ofFigure 1 Flow chart of study selection. RCT, randomized controlled trialresuscitation of hemorrhagic shock [12]. Another
study claimed the prediction value of pHi on the sur-
vival rate of 20 children was better than traditional
assessments (base deficit, blood lactate level, arterial
pH, and so on) [13]. Perilli and colleagues performed
a study which showed that gastric tonometry could.
Figure 2 Effects of gastric tonometry guided therapy versus control groups on hospital mortality. CI, confidence interval; OR, odds ratio;
W, weight of each study.
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transplantation [14].
Based on the evidence mentioned above, it is reasonable
for us to suggest the hypothesis that normalizing pHi or
the difference between gastric mucosal and arterial PCO2
(PCO2 gap) could improve the outcome of critical care
patients. In some published randomized controlled
trials (RCTs), patients were randomized into experi-
ment and control groups. In the intervention groups,
the value of pHi was determined at regular intervals.
If the pHi values were lower than the normal value,
the patients would receive treatments according to
the predefined methods such as fluid infusion, vaso-
active agent administration, blood transfusion, and so
forth, to improve the pHi. The patients in control
groups were treated without the guidance of pHi.
Gutierrez and colleagues studied 260 patients in the
ICU and discovered that gastric tonometry guided
therapy could increase the survival rate of patients
whose pHi values were normal on admission to the
ICU [15]. However, five other RCTs failed to demonstrate
patients benefiting from this therapy [16-20]. Hence, we
undertook a meta-analysis to explore whether the gastric
tonometry guided therapy yielded measurable benefits in
critical care patients.
Materials and methods
Data sources and searches
Three authors (XZ, WX and XDW) independently
searched PubMed, EMBASE, the Cochrane Library and
ClinicalTrials.gov using the following search strategy:Figure 3 Effects of gastric tonometry guided therapy versus control g
W, weight of each study.“gastric tonometry” OR “intramucosal pH” OR “gastro-
intestinal pH” OR “gut intramucosal pH” OR “gastric
PCO2” OR “gastric intramucosal-arterial PCO2” OR “gas-
tric mucosal pH”, confining the article type to RCT or
trial. There was no language restriction in our search
strategy. The search scope for these databases was from
their inception to May 2014.Study selection
Three authors (XZ, WX and PY) discussed and defined
the inclusion and exclusion criteria. The inclusion criteria
were: adult patients admitted to the ICU; and studies in
which patients were randomly divided into at least two
groups, including a group of patients being treated with
the intent to normalize the value of pHi or the PCO2 gap.
During the process of article selection, three authors
(XZ, WX and XDW) came to an agreement on the
divergence by discussion with another two authors
(PY and QPW). We excluded research that was updated
in a later published paper or was designed as a historical
controlled trial.Data extraction and quality assessment
Baseline characteristics (population, mean age, Acute
Physiology and Chronic Health Evaluation II scores on
admission, intervention, current treatment, number of
patients, outcomes used in the meta-analysis) of the
included RCTs were extracted independently by three
authors (XZ, WX and XDW) and the final results are
displayed in Table 1.roups on total mortality. CI, confidence interval; OR, odds ratio;
Figure 4 Effects of gastric tonometry guided therapy versus control groups on total mortality using risk difference. CI, confidence interval;
RD, risk difference; W, weight of each study.
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authors (XZ, WX and XDW) according to the Cochrane
Handbook for Systematic Reviews of Interventions
(Table 8.5.d [21]). We arrived at a consensus over the
disagreements by discussion with another two authors
(PY and QPW). The final results are displayed in Table 2.
Outcome
Primary outcomes were hospital mortality, total mortality
and ICU mortality. The secondary outcomes were ICU
length of stay, hospital length of stay and days intubated.
All of the included RCTs provided the survival rate or
mortality rate (Table 1). We transformed the survival rates
into mortality rates. Two studies reported survival data or
mortality data without stating explicitly which survival
measure or mortality measure (30-day survival or hospital
survival or 30-day mortality or hospital mortality) was
used; we found that 30-day mortality was very similar to
hospital mortality in Gomersall and colleagues’ [16]
article, so we finally integrated all of the mortality data for
the included RCTs and called it total mortality to obtain a
larger sample size – hospital mortality provided by
Gomersall and colleagues was used in the combination.
We found that some continuous data’s standard deviation
(SD) values for these included RCTs exceeded their mean
values, which may indicate that the data were not
normally distributed. As the published studies reported
data in the format of mean (SD), data were pooled
assuming they were normally distributed. We extracted
and analyzed the ICU length of stay and hospital length of
stay for the purpose of roughly estimating consumption ofFigure 5 Sensitivity analysis of total mortality. CI, confidence interval; Omedical resources. Sensitivity analysis for total mortality
and subgroup (patients with or without normal admission
pHi) analysis for ICU mortality and hospital mortality
were performed to explore whether the gastric tonometry
guided therapy had significant effects on a specific group
of patients.
Data synthesis
Data were analyzed using R3.1.0 (The R Foundation for
Statistical Computing, Vienna, Austria) and P <0.05 was
considered significant. For dichotomous outcomes, pooled
odds ratios (ORs) with 95% confidence intervals (CIs) were
calculated based on the Mantel–Haenszel method for
random-effects models. Continuous outcomes were pre-
sented as standardized mean differences (SMDs) together
with 95% CIs using the inverse variance method for
random-effects models. The baseline mortality of ICU
patients in different hospitals was not the same and has
been decreasing significantly over time, so we used another
measure of effect (risk difference) to reassess the effect of
gastric tonometry on total mortality (the only positive
outcome). The mean value and SD of trials in which only
the median, range, and sample size were reported were
calculated according to the formula provided by Hozo
and colleagues [22]. Using the formula provided by
the Cochrane Handbook for Systematic Reviews of
Interventions (table 7.7.a [21]), we calculated the combining
mean value and SD from two groups. We used the I2 statis-
tic to evaluate statistical heterogeneity, and significant
heterogeneity was predefined as I2 > 50%. In all of the forest
plots, leftward favors gastric tonometry and rightwardR, odds ratio; W, weight of each study.
Figure 6 Effects of gastric tonometry guided therapy versus control groups on ICU mortality. CI, confidence interval; OR, odds ratio; W,
weight of each study.
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tality of the population receiving nongastric tonometry
guided therapy was equal to the combined control group
statistics provided by total mortality analysis. To evaluate
the proper sample size to detect a 10% mortality reduction
in the protocol group compared with the control group, we












δ ¼ PE−PC; P
— ¼ PE þ PCð Þ
2
; α ¼ 0:05; β ¼ 0:1Þ
Publication bias
According to the Cochrane Handbook for Systematic
Reviews of Interventions, when the number of included
studies in the meta-analysis was <10, the power of the
traditional method to assess publication bias was very
low [21]. We therefore did not evaluate the publication
bias using the traditional method.
Results
Search result
We identified 11,014 citations. After restricting the article
type to RCT or trial, 10,413 studies were excluded.
According to the inclusion and exclusion criteria, 23 RCTs
were selected for further evaluation. Of these, 14 were
duplicate studies, one was designed as a historical con-
trolled trial, one RCT was updated in a later published
paper and one trial was performed in children. This
resulted in a total of six RCTs being selected for our
meta-analysis (Figure 1).Figure 7 Effects of gastric tonometry guided therapy versus control g
deviation; SMD, standardized mean difference; W, weight of each study.Primary outcomes
Hospital mortality
Three studies reported hospital mortality of pHi groups
when compared with control groups [15,16,20]. The
pooled data revealed that gastric tonometry guided
therapy did not significantly reduce the hospital mor-
tality (OR, 0.741; 95% CI, 0.516 to 1.064, P = 0.104)
(Figure 2). There was no significant heterogeneity in
these studies (I2 = 0%).Total mortality
The combined data showed that gastric tonometry
guided therapy significantly reduced total mortality (OR,
0.732; 95% CI, 0.536 to 0.999; P = 0.049) (Figure 3).
There was no heterogeneity (I2 = 0%). Using risk difference
as the measure of effect yielded a similar result (risk differ-
ence, −0.056; 95% CI, −0.109 to −0.003, P = 0.038; I2 = 0)
(Figure 4).
Two trials reported patients with normal pHi on
admission [15,16], so a sensitivity analysis was per-
formed to exclude these patients. The pooled results
showed that gastric tonometry guided therapy could
not reduce the total mortality (OR, 0.736; 95% CI 0.506 to
1.071, P = 0.109; I2 = 0%) (Figure 5).ICU mortality
Two trials reported ICU mortality [15,16] and the aggre-
gation of them showed that gastric tonometry guided
therapy could not reduce ICU mortality (OR, 0.704;
95% CI, 0.402 to 1.235, P = 0.221) (Figure 6). Significant
heterogeneity was observed (I2 = 56.5%).roups on ICU length of stay. CI, confidence interval; SD, standard
Figure 8 Effects of gastric tonometry guided therapy versus control groups on hospital length of stay. CI, confidence interval; SD,
standard deviation; SMD, standardized mean difference; W, weight of each study.
Zhang et al. Critical Care  (2015) 19:22 Page 8 of 11Secondary outcomes
ICU length of stay
The effects of gastric tonometry guided therapy on the
ICU length of stay were reported in four trials [16,18-20].
Three trials reported the mean (SD) stay [18-20] and one
trial reported the median (range) [16]. The combined data
suggested that gastric tonometry guided therapy could not
significantly reduce the days spent in the ICU (SMD, 0.104;
95% CI, −0.072 to 0.280, P = 0.247; I2 = 0%) (Figure 7).
Hospital length of stay
Three studies evaluated the impact of gastric tonometry
guided therapy on hospital length of stay [16,18,20]. No
differences were observed between the two protocols
(SMD, 0.049; 95% CI, −0.155 to 0.253, P = 0.637; I2 = 0%)
(Figure 8).
Days intubated
Two trials investigated the duration of mechanical
ventilation [18,20]. The combined data showed gastric
tonometry guided therapy could not diminish the number
of days of intubation (SMD, −0.031; 95% CI, −0.342 to
0.280, P = 0.846; I2 = 0%) (Figure 9).
Subgroup analysis
Two RCTs performed subgroup analysis for ICU mortality
and hospital mortality based on the admission pHi of
patients [15,16]. The pooled data revealed that gastric
tonometry guided therapy could not diminish the ICU
mortality (OR, 0.597; 95% CI, 0.145 to 2.468, P = 0.476;
I2 = 64.4%) (Figure 10) or the hospital mortality (OR,
1.049; 95% CI, 0.216 to 5.091; P = 0.953; I2 = 77.8%)
(Figure 11) of patients with normal admission pHi.Figure 9 Effects of gastric tonometry guided therapy versus control g
standard deviation; SMD, standardized mean difference; W, weight of eachObvious heterogeneity was observed between the two
trials. The combined results of patients without nor-
mal admission pHi showed similar results for the
two outcomes (ICU mortality: OR, 0.926; 95% CI,
0.571 to 1.502; P = 0.755; I2 = 0%; hospital mortality:
OR, 0.771; 95% CI, 0.475 to 1.251; P = 0.293; I2 = 0%)
(Figures 12 and 13).Sample size evaluation
The proper sample size of each group was 469, and the
number of total patients was about 938; none of the six
RCTs meet this requirement. The sample size of total
mortality data was 816, approaching the requirement, so
the combined result may be more persuasive than any of
the six RCTs.Publication bias
As Figures 3 and 4 show, all 95% CIs of ORs (or risk
differences) of the included studies cross the vertical
solid line, which means none of the included RCTs
showed significant results, so the publication bias could
be excluded [24].Discussion
This meta-analysis showed that gastric tonometry guided
therapy reduced total mortality of critical care patients
when compared with control groups. However, there
was no difference in hospital mortality, ICU mortality,
ICU length of stay, hospital length of stay or intubation
days. This may be the case that the effects of gastric
tonometry guided therapy are not apparent and require a
relative big sample size to be detected.roups on number of days intubated. CI, confidence interval; SD,
study.
Figure 10 Subgroup analysis of ICU mortality for patients with normal admission gastric intramucosal pH. CI, confidence interval; OR,
odds ratio; W, weight of each study.
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after dividing patients of both experiment and control
groups into two subgroups based on admission pHi; they
demonstrated that patients with normal admission pHi
had significantly higher survival rate in the experimental
group [15]. Another study using the mortality rate as the
outcome performed similar subgroup analysis and failed
to demonstrate this benefit [16]. We transformed the
survival rate of the first study into the mortality rate and
pooled the results of the two articles; the combined data
showed that gastric tonometry guided therapy could not
reduce the mortality of patients with normal admission
pHi, and statistical heterogeneity was observed between
the two trials (Figures 10 and 11). However, we could
not conclude that gastric tonometry guided therapy
has no beneficial effects on the patients with normal
admission pHi. For one thing, the sample size of patients
with normal admission pHi in the second study [16] was
too small and the combining sample size (Figures 10
and 11) was also relatively small, which may make it
underpowered to detect the effects of gastric tonometry
guided therapy and result in statistical heterogeneity. Also,
the difference in pathophysiological states of patients in
the two studies may also contribute to the outcome
heterogeneity; the effect of gastric tonometry guided
therapy may be different in various disease/health
conditions. We performed a sensitivity analysis excluding
these patients using total mortality as the outcome, and
the pooled result (Figure 5) showed that the beneficial
effects disappeared. This may indicate that the patients
with normal admission pHi contributed to the ultim-
ate combined results of total mortality and these
patients may be more sensitive to gastric tonometry
guided therapy.Figure 11 Subgroup analysis of hospital mortality for patients with n
OR, odds ratio; W, weight of each study.The methodology of gastric tonometry has been
severely debated. The calculated value of pHi is a
combination of locally ( PCO2 in the stomach) and
systemic (atrial bicarbonate content) derived indexes;
the calculation is based on the assumption that the
atrial bicarbonate content is equal to the mucosal
content. However, the bicarbonate concentration of
ischemic mucosa may not equal that in arterial blood
[25], so the pHi may not reflect the actual pH of the
mucosa layer. An animal study demonstrated that an
increase of the PCO2 gap was highly correlated with a
reduction of gastric blood flow [26], suggesting that
the PCO2 gap was a better index than pHi to reflect
the splanchnic hypoperfusion. Other research also
favored using the PCO2 gap as a marker of tissue
ischemia [27]. Jakob and colleagues’ research, however,
included 22 patients after cardiac surgery and con-
cluded that an increase in the PCO2 gap may be explained
partly or totally by the Haldane effect [28], so the
PCO2 gap may also be flawed in reflecting the perfu-
sion state of mucosa. In general, the exact physiology
meaning of pHi and the PCO2 gap need further investiga-
tion to elucidate.
Despite the methodology arguments of gastric tonom-
etry, through this meta-analysis we found that improving
the pHi could reduce total mortality in critical care
patients. One RCT reported that their failure to
improve the outcome may be caused by an inability to
produce a significant change of pHi [16]. Therefore,
exploring which kind of method could improve the
pHi or PCO2 gap is important. Levy and colleagues
carried out research demonstrating that the PCO2 gap
of septic shock patients treated with norepinephrine
could be inconsistently improved by low dose oformal admission gastric intramucosal pH. CI, confidence interval;
Figure 12 Subgroup analysis of ICU mortality for patients without normal admission gastric intramucosal pH. CI, confidence interval;
OR, odds ratio; W, weight of each study.
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that different patients have different sensitivity to
dobutamine and dopexamine; the use of them should
be individual. Other research showed levosimendan,
olprinone, enalaprilat and rapid volume infusion could
improve the pHi values or PCO2 gap [30-33]. However,
all authors of the mentioned studies performed their
experiments in particular groups of patients; whether
these treatments could produce significant effects in
all critical care patients is unknown.
Few institutions use gastric tonometry in clinical
practice because it has been severely questioned in
the aspect of its methodology and physiology mean-
ing. As our study provided some evidence supporting
the use of this technique, this may indicate that the
pHi and PCO2 gap represent a physiological state in
which changes could affect the prognosis of critical
care patients. The current explanations of the
physiological meaning of this technique are diver-
gent; we believe the pHi or PCO2 gap is not a sim-
plex index indicating a simplex meaning, but is a
compound index of multiple physiological or patho-
physiological states. If convincing and profound in-
terpretation for gastric tonometry is raised by future
researchers, this technique may return to clinical
practice.
Some limitations to this meta-analysis deserve dis-
cussion. First of all, although the heterogeneity of
most outcomes was not significant, the clinical base-
line characteristics of included patients were not the
same among the six studies (Table 1); this may make
our study underpowered to detect concealed but
important differences between gastric tonometry
guided therapy and controls, but may also indicateFigure 13 Subgroup analysis of hospital mortality for patients withou
interval; OR, odds ratio; W, weight of each study.that gastric tonometry guided therapy is universal
for various kinds of patients. Second, these RCTs de-
fined different normal values of pHi and the treat-
ment guidelines of experimental and control groups
were also differential; this could result in heteroge-
neous outcomes of patients and then underestima-
tion or exaggeration of the conclusion of this study.
Another limitation was that one study did not men-
tion whether their patients received gastric acid
inhibition [16], so the precise value of pHi may be
affected to a degree. Finally, Correa-Martin and col-
leagues performed two studies and demonstrated
that tonometry was sensitive to the increase of intra-
abdominal pressure [34,35], but none of the included
six studies excluded patients with high intra-abdominal
pressure.
Conclusions
Gastric tonometry guided therapy can reduce total
mortality of critical care patients. Treatments that
improve organ microcirculation may be recom-
mended for resuscitation of critical care patients if
not contraindicated. Gastric tonometry guided ther-
apy may be more effective in some specific critical
care patients. Further investigation needs to be carried
out to interpret the physiological meaning of gastric
tonometry.
Key messages
 Gastric tonometry guided therapy can reduce total
mortality of critical patients.
 Some specific critical care patients may be more
sensitive to gastric tonometry guided therapy.t normal admission gastric intramucosal pH. CI, confidence
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